Journal of Psychosomatic Research
Volume 61, Issue 6 , Pages 783-789 , December 2006

Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention

  • Susanne S. Pedersen

      Affiliations

    • Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    • Centre of Research on Psychology in Somatic diseases (CoRPS), Tilburg University, The Netherlands
    • Corresponding Author InformationCorresponding author. CoRPS, Department of Medical Psychology, Room P503a, Tilburg University, Warandelaan 2, PO Box 90153, 5000 LE Tilburg, The Netherlands. Tel.: +31 13 466 2503; fax: +31 13 466 2370.
    • ,
  • Johan Denollet

      Affiliations

    • Centre of Research on Psychology in Somatic diseases (CoRPS), Tilburg University, The Netherlands
    • ,
  • Helle Spindler

      Affiliations

    • Department of Psychology, Aarhus University, Denmark
    • ,
  • Andrew T.L. Ong

      Affiliations

    • Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    • ,
  • Patrick W. Serruys

      Affiliations

    • Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    • ,
  • Ruud A.M. Erdman

      Affiliations

    • Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    • Department of Medical Psychology and Psychotherapy, Erasmus Medical Centre Rotterdam, The Netherlands
    • ,
  • Ron T. van Domburg

      Affiliations

    • Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands

Received 10 February 2006 ,Revised 23 May 2006 ,Accepted 27 June 2006.

References 

  1. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–813
  2. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JFP, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814–822
  3. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290:215–221
  4. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811–1817
  5. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005;111:250–253
  6. Strik JJ, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol. 2003;19:1801–1807
  7. Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. Effects of depression and anxiety on mortality and quality of life 4 months after myocardial infarction. J Psychosom Res. 2000;49:229–238
  8. Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med. 2001;63:221–230
  9. Sullivan MD, LaCroix AZ, Spertus JA, Hecht J. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol. 2000;86:1135–1138
  10. Sullivan MD, LaCroix AZ, Baum C, Grothaus LC, Katon WJ. Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med. 1997;103:348–356
  11. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med. 2000;62:212–219
  12. Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease. Circulation. 2005;111:3158–3166
  13. Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med. 2004;66:645–650
  14. Goodwin RD. Anxiety disorders and the onset of depression among adults in the community. Psychol Med. 2002;32:1121–1124
  15. Zimmerman M, Chelminski I. Generalized anxiety disorder in patients with major depression. Is DSM-IV's hierarchy correct?. Am J Psychiatry. 2003;160:504–512
  16. Lenze EJ, Mulsant BH, Shear MK, Shulberg HC, Dew MA, Begley AE, et al. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry. 2000;157:722–728
  17. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157:956–962
  18. Rinfret S, Grines CL, Cosgrove RS, Ho KKL, Cox DA, Brodie BR, et al. Quality of life after balloon angioplasty or stenting for acute myocardial infarction. J Am Coll Cardiol. 2001;38:1614–1621
  19. Weaver WD, Reisman MA, Griffin JJ, Buller CE, Leimgruber PP, Henry T, et al. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-I): a randomised trial. Lancet. 2000;355:2199–2203
  20. Krumholz HM, Cohen DJ, Williams C, Baim DS, Brinker J, Cabin HS, et al. Health after coronary stenting or balloon angioplasty: results from the Stent Restenosis Study. Am Heart J. 1997;134:337–344
  21. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  22. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  23. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, et al. Unrestricted utilization of sirolimus-eluting stents compared to conventional bare metal stent implantation in the “real world.” The Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004;109:190–195
  24. Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, et al. Early outcome after sirolimus eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol. 2003;41:2093–2099
  25. Pedersen SS, Lemos PA, van Vooren PR, Liu TKK, Daemen J, Erdman RAM, et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry sub-study. J Am Coll Cardiol. 2004;44:997–1001
  26. Lemos PA, Serruys PW, van Domburg RT. Sirolimus-eluting stents in the ‘real world’: the RESEARCH registry rationale and study design. In:  Serruys PW,  Lemos PA editor. Sirolimus-eluting stents: from RESEARCH to clinical practice. London: Taylor & Francis; 2005;p. 17
  27. Rumsfeld JS, Magid DJ, Plomondon ME, Sacks J, Henderson W, Hlatky M, et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol. 2003;41:1732–1738
  28. Strauss WE, Fortin T, Hartigan P, Folland ED, Parisi AF. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with medical therapy: Veterans Affairs Study of Angioplasty Compared to Medical Therapy investigators. Circulation. 1995;92:1710–1719
  29. Seto TB, Taira DA, Berezin R, Chauhan MS, Cutlip DE, Ho KK, et al. Percutaneous coronary revascularization in elderly patients: impact on functional status and quality of life. Ann Intern Med. 2000;132:955–958
  30. Poston WSC, Haddock CK, Conard MW, Jones P, Spertus J. Assessing depression in the cardiac patient: when is the appropriate time to assess depression in the patient undergoing coronary revascularization?. Behav Mod. 2003;27:26–36
  31. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  32. Bjelland I, Dahl AA, Haug TT, Neckelman D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77
  33. Herrmann C, Brand-Driehorst S, Buss U, Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 2000;48:455–462
  34. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care. 1993;30:473–483
  35. Smith HJ, Taylor R, Mitchel A. A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart. 2000;84:390–394
  36. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Nathan RE, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J. 2003;145:493–499
  37. Surtees PG, Wainwright NWJ, Khaw K-T, Day NE. Functional health status, chronic medical conditions and disorders of mood. Br J Psychiatry. 2003;183:299–303
  38. Vaccarino V, Lin ZQ, Kasl SV, Mattera JA, Roumanis SA, Abramson JL, et al. Sex differences in health status after coronary artery bypass surgery. Circulation. 2003;108:2642–2647
  39. Zimmerman M, Chelminski I. Clinician recognition of anxiety disorders in depressed outpatients. J Psychiatr Res. 2003;37:325–333
  40. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom. 2004;73:344–352

PII: S0022-3999(06)00337-0

doi: 10.1016/j.jpsychores.2006.06.009

Journal of Psychosomatic Research
Volume 61, Issue 6 , Pages 783-789 , December 2006

Article Tools

* Image Usage & Resolution